Alex Gorsky is the Co-Founder of Alderline Group and a General Partner at ICONIQ Capital. He is the former Chairman and CEO of Johnson & Johnson, where he served for ten years. During his tenure as CEO, Johnson & Johnson developed lifesaving cancer therapies, deployed Ebola vaccines in Africa, advanced robotic surgery technologies, and achieved end-to-end development of the Janssen COVID-19 vaccine in 13 months.